Alliances
Todos Medical Ltd. and Orot+ announced the enrollment of the first patient in the pre-commercial launch study of TM-B1 and TM-B2 in Europe.
Silence Therapeutics, PLC announces the triggering of the first $2 million in research milestones for SLN500 under the collaboration with Mallinckrodt Pharmaceuticals, a global biopharmaceutical company.
Firma Clinical Research, a niche service provider, is partnering with The Myositis Association on a multi-faceted project to better integrate the experience of patients into the training of clinical trial investigators and support providers.
Germany-based Evotec is partnering with Japan’s Takeda Pharmaceutical to develop at least five drug discovery programs across a broad range of indications.
Fujitsu and PeptiDream Leverage Quantum-Inspired Tech in Joint Research to Accelerate Drug Discovery
Fujitsu’s Quantum-Inspired Digital Annealer technology applied to drug discovery process to streamline the search for candidate compounds
APEX Biologix, a nationally recognized leader in manufacturing and distributing cutting-edge biologic supplies will now have access to an exciting new product.
Aiming to Expand Availability of Eribulin to Patients in India with Two Brands Halaven and Teceris
The Case-Coulter Translational Research Partnership (CCTRP) between Case Western Reserve University and the Wallace H. Coulter Foundation has announced more than $1.1 million in 2019 funding and support for seven biomedical technologies.
Helsinn and Recordati Rare Diseases announce that a co-sponsored Symposium, organized by the two companies at the European Society for Dermatological Research Annual Meeting, , will provide a better knowledge of Chlormethine Gel’s mode of action as well as guidance on the management of the Chlormethine gel induced dermatitis.
Bayer, Brigham and Women’s Hospital and Massachusetts General Hospital have launched a joint laboratory to research new drugs to treat chronic lung diseases.
PRESS RELEASES